Editor’s Note: This post is brought to you by Miriam Kingsberg, an assistant professor in the department of history at the University of Colorado, Boulder. This summer she visited the Deutsches Apotheken-Museum in Munich and has provided us with a review of its collections. All photos are courtesy of her as well. Enjoy!
During a two-month sojourn in Germany this summer, I eagerly anticipated a visit to Munich’s famed Beer and Octoberfest Museum—in the name of “research,” naturally. Less renowned than this hotspot and its many sister institutions, but equally relevant to historians of intoxicants, is the country’s sole attempt to reconstruct its pharmaceutical history: the Deutsches Apotheken-Museum (hereafter referred to as DAM), located since 1958 in the breathtaking Heidelberg Castle.
The exterior of the Deutsches Apotheken-Museum
Continue reading →
Editor’s Note: This post is brought to you by Marco Ramos and Tess Lanzarotta. Ramos is an MD/Ph.D. candidate in the History of Science and Medicine program at Yale University focusing on the production and circulation of scientific knowledge during the Cold War in the global south. Lanzarotta is a Ph.D. candidate in the same department focusing on the ways that contemporary interactions between biomedical researchers and indigenous populations are shaped by their historical antecedents. Together, Ramos and Lanzarotta are teaching a course on the history of drugs in the twentieth century and we’ve invited them to contribute to our “Teaching Points” series. Enjoy!
The idea for our course on the history of drugs developed out of a conversation a few years ago concerning the medical management of opiate addiction in our community of New Haven, CT. We are both graduate students in the Program in the History of Science and Medicine at Yale University, and Marco is also a medical student at Yale School of Medicine. Having recently completed a clinical rotation at the hospital, Marco reflected on the patient-blaming and suspicion that often accompanies discussions of opiate prescription among physicians. During his rotation, he heard physicians and residents bemoan their patients who requested, and often demanded, opiate prescriptions. He watched as physicians speculated about whether patients were “feigning” their pain to acquire drugs and realized that physicians made judgments about who should receive opiate prescriptions based on imperfect, biased assumptions about what “addicts” looked like racially and economically. Given the large body of medical evidence that demonstrates addiction is not a matter of voluntary choice or individual responsibility, Marco wondered why physicians continued to blame and shame patients for their struggles with addiction.
Tess pointed to the utility of history in understanding opiate addiction in the United States today. She discussed the pharmaceutical companies’ role in this story, as the industry downplayed the addictiveness of opiates and encouraged their widespread use for profit in the medical community throughout the 1980s and 90s. A long history of inadequate consumer protections from the Food and Drug Administration did not safeguard patients from the rapid circulation of this dangerous class of drugs during this period. Though the pharmaceutical industry and a weak federal regulatory body were largely to blame for the growing incidence of opiate addiction across the country, drug enforcement held individual patients responsible for their addictions.
As the conversation progressed, we began to reflect on the importance of history for understanding dilemmas — like opiate addiction — presented by drugs today. We imagined a course that would focus on the history of drugs as a way of generating “useful pasts” that could inform how our students thought about drugs and drug policy in the present. As our thinking evolved, we drafted an application to co-teach a course that centered on the categorization of drugs across the twentieth century. Rather than using drugs as a lens to understand social, cultural, legal, or political history in the Unites States, we hoped to use history to reflect on drug categories themselves. We were interested in how lines dividing chemically active substances into categories and classes, such as illicit and licit or medical and recreational, have shifted across the twentieth century. Historically shifting boundaries between drugs have hinged upon changing cultural norms surrounding the characterization of “use” versus “abuse,” the prescribed treatments or punishments for drug users, and the labelling of drug use as an individual or social problem. Such beliefs continue to be wrapped up in socially-mediated understandings of identity — along ethnic, racial, gender, class, and religious lines — and in opposing ideologies of health and governance.
Continue reading →
Editor’s Note: This post is brought to you by Liz Greene, a history geek and an anxiety-ridden realist from the beautiful city of trees, Boise, Idaho. You can follow her latest misadventures on her blog, Instant Lo. Enjoy!
When it comes to failed social experiments in U.S. history, Prohibition takes the cake. Far from ushering in the utopian society promised by the temperance movement, Prohibition only succeeded in making matters much worse.
The new law was met with outright rebellion. Bootleggers made a fortune distilling and selling alcohol. Thousands of speakeasies popped up, serving a thirsty population who cared little for the legality of the situation. Organized crime rose to the forefront, distributing booze, warring with rival gangs, and taking out innocent bystanders in the process. Murder became a familiar headline. 
But the mob and unskilled bootleggers weren’t the only ones causing death and destruction during Prohibition. The federal government had a large role to play as well.
Continue reading →